Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes
- PMID: 1563019
- PMCID: PMC11038437
- DOI: 10.1007/BF01741753
Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes
Abstract
In this study we analysed the in vitro effect of recombinant interferon gamma on cytotoxic activities mediated by both lymphoid and polymorphonuclear cells from 16 patients with myelodysplastic syndromes. Our results indicate the inability of interferon to restore the defective natural killer activity, natural killer cells and lectin-induced cytotoxicity. On the contrary we detected a boosting effect on the depressed polymorphonuclear cell cytotoxic activities. In our view, the ability of interferon to potentiate polymorphonuclear cell lytic efficiency could support an alternative defensive pathway against either neoplastic or infectious agents.
References
-
- Baumann MA, Milson TJ, Patrick CW, Libnock JA, Keller RH. Immunoregulatory abnormalities in myelodysplastic disorders. Am J Hematol. 1986;22:17. - PubMed
-
- Bennet JM, Catovsky D, Daniel MT. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med. 1985;103:626. - PubMed
-
- Beran M, Hansson M, Kiessling R. Human natural killer cells can inhibit clonogenic growth of fresh leukemic cells. Blood. 1983;61:596. - PubMed
-
- Boogaerts MA. Progress in the therapy of myelodysplastic syndromes. Blut. 1989;58:265. - PubMed
-
- Boogaerts MA, Nelissen V, Roelant C, Goossens W. Blood neutrophil functions in primary myelodysplastic syndromes. Br J Haematol. 1983;55:217. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical